FDA BLA · BLA761347
TECENTRIQ HYBREZA
Sponsor: GENENTECH INC
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
BLA761347
TYPE
BLA
ORIGINAL APPROVAL
2024-09-12
LATEST ACTION
2026-10-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
TECENTRIQ HYBREZAPrescription
ATEZOLIZUMAB AND HYALURONIDASE-TQJS 125MG · INJECTABLE · INJECTION
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →